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ABSTRACT
The use of Doppler ultrasound in rheu-
matology has grown in recent years. 
This is partly due to the increasing 
number of rheumatologists who per-
form US in their daily clinical practise 
and also to the technological advances 
of US systems. Both colour Doppler and 
power Doppler are used to evaluate the 
degree of intra- and peri-articular soft 
tissue infl ammation. Moreover, Dop-
pler US has been found to be of help in 
the assessment of vascular pathologies 
such as the vasculitides. In this review 
we provide an update of the data regard-
ing the use of colour Doppler and power 
Doppler in rheumatology.
Introduction
Ultrasonography (US) has rapidly come 
to the fore in recent years as one of the 
most important tools that can be used by 
rheumatologists to study several rheu-
matic conditions (1). The role of Dop-
pler US has expanded in the last dec-
ade with the improvement of both the 
hardware and software of US machines. 
There is now no doubt that Doppler US 
plays a key role in the assessment of 
tissue perfusion in several pathological 
conditions (i.e., synovitis, tenosyno-
vitis, bursitis, enthesitis, vasculitis) in 
rheumatology (2-9). Both colour Dop-
pler (CD) and power Doppler (PD) are 
valuable techniques to show the level 
of vascularisation of the musculoskel-
etal structures, in order to evaluate in-
fl ammation and to monitor treatment 
response in joints and periarticular soft 
tissues. In this review we discuss the 
current data relating to the application 
of CD and PD in rheumatology.
What is Doppler US?
Essentially, this is a technology based 
upon the “Doppler effect”, fi rst described 
by the Austrian physicist Christian 
Doppler in 1842. It is a change in the 
frequency of a sound wave due to the 
movement of either its source or receiv-
er. US medical systems use the “Dop-
pler effect” generated by the movement 
of the erythrocytes in the vascular sys-
tem and provide information on blood 
fl ow velocity and direction (8, 10, 11). 
At least fi ve different types of Doppler 
techniques are now available, including 
continuous-wave Doppler, pulsed-wave 
Doppler, Duplex, CD and PD US. 
CD and PD are the most studied and 
widely used in rheumatology because 
they allow the simultaneous visualisa-
tion of grey-scale and Doppler fi ndings 
providing information on the exact ana-
tomic distribution and the entity of the 
blood fl ow. 
CD displays the direction and the mean 
velocity of blood fl ow, while PD has been 
developed in order to increase sensitivity 
of low blood fl ow, without displaying ei-
ther direction or velocity. For the assess-
ment of pathologic conditions such as 
synovitis or enthesitis, the detection of 
even minimal abnormal vascularisation 
is more important to the rheumatologist 
than the acquisition of information on 
fl ow direction and/or velocity. 
Thus, the higher sensitivity of PD US 
and its more user-friendly application 
(it is independent of the US beam direc-
tion and does not generate aliasing) has 
made it more popular among rheuma-
tologists. 
In the latest generation US systems, the 
difference between CD and PD US is 
not so evident because CD has gained 
in sensitivity and PD provides informa-
tion also on the fl ow direction. 
Indications and clinical 
applications of Doppler US
Doppler US techniques provide a sen-
sitive detection of blood fl ow both in 
small and large vessels.
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In patients with chronic arthritis, PD 
US allows an estimation of disease ac-
tivity at joint level as well as in tendons 
and entheses (3, 12-14). In patients 
with vasculitis, CD evaluation of in-
volved large vessels may reveal blood 
fl ow abnormalities both in its direction 
and velocity. 
Recent studies suggested that US short 
term monitoring provides information 
on therapy effi cacy, disease progres-
sion and remission (15-22). 
A signifi cant statistical reduction of 
intra-articular PD signal can be docu-
mented, at least 6 weeks (18) to 3 
months (16) in RA patients receiving 
biologic therapy, while a shorter period 
(no longer than 2 weeks) is required 
to depict sometimes even relevant de-
creases of PD signal after intra-articu-
lar steroid injection treatment in pa-
tients with chronic arthritis (19).
In a placebo-controlled double-blind 
randomized study conducted on 24 
consecutive patients with early rheu-
matoid arthritis, PD US assessment 
of joint infl ammation was compared 
with the rate of radiographic damage at 
one year. After 18 weeks of follow-up, 
PD US fi ndings at metacarpophalan-
geal joint level were found successful 
in discriminating the group with the 
lower rate of radiographic progression 
of bony erosions (15). Moreover, in a 
recent longitudinal study carried out on 
42 patients with early rheumatoid ar-
thritis, a positive correlation was found 
between the persistence of intra-artic-
ular PD US signal obtained in the 28 
joints of the 28-joint Disease Activity 
Score and the radiographic progression 
at one year (21).
The role of PD US in revealing sub-
clinical joint infl ammation was inves-
tigated in a cohort of 107 RA patients 
in clinical remission and in 43% of 
asymptomatic patients with clinically 
normal joints, abnormal intra-articular 
PD signal was found at the level of the 
wrist and MCP joints of the dominant 
hand (22).
Quantifi cation methods 
Essential requirement for US short-
term monitoring is a reliable quantifi -
cation method for assessing abnormal 
soft tissue vascularisation (23-28).
In the last decade, several different 
approaches have been developed in 
chronic infl ammatory arthritis (mostly 
for assessing synovitis, only a few for 
enthesitis), including: presence/absence 
of signal at single or multiple anatomic 
sites, semiquantitative evaluation of 
PD and/or CD Doppler signal, colour 
pixel or voxel count, spectral Doppler 
evaluation, contrast enhanced, three-
dimensional (3D) blood vessel count.
The detection of presence/absence of PD 
signal may appear more reproducible if 
compared with semiquantitative meth-
ods but there is evidence that its pres-
ence may also be detected in small joints 
of healthy subjects and this is especially 
true for the wrist (25). Which anatomic 
sites (joints or entheses) to examine and 
which acoustic windows to use, have not 
yet been established. In recent literature, 
it is possible to fi nd some proposals by 
Naredo et al. (27), de Miguel et al. (14) 
and D’Agostino et al. (28). 
Semiquantitative evaluation of col-
our signal is the most commonly used 
method in clinical practice and it has 
also been used in several clinical stud-
ies to defi ne increased vascularisation. 
A nominal scale (0-3) of the intra-ar-
ticular PD signal intensity is used as 
follows: grade 0, no Doppler signal or 
no fl ow; grade 1, single vessel signal or 
mild fl ow; grade 2, confl uent signals or 
moderate fl ow; grade 3, more than 50% 
of the area of the synovial membrane 
with signal, or severe fl ow.   
There is a number of dedicated soft-
ware which allows the quantifi cation of 
colour pixels and voxels, respectively 
in 2D and 3D images (8, 10, 11, 15, 20, 
21). There is evidence that the results 
Table I. PD setting.
Table II. US artefacts.
Higher for the study of small joints and superfi cial tissues (7.5-12 
MHz), lower for deep structures (5-7 MHz).
Lowest possible. The most commonly PRF value used in 
rheumatology is between 0.5 and 1.0 KHz.
Just below the level that causes the appearance of noise artefacts.
Lowest possible.
Positioned at the level of the region of interest.
Lowest possible.
Adjusting a small colour box avoids slowing down the moving 
fl ow; in fact, frame rate decreases when colour is added and small 
box contains less colour. However, to avoid misinterpretation due 
to reverberation artefacts, it is recommended enlarging the box to 
upper part of the image.
Doppler frequency  
Pulse repetition frequency (PRF) 
Colour Doppler gain 
Persistence  
Focus 
Wall fi lter 
Colour box 
(position and size)
Occurs only while using CD and spectral Doppler. Aliased signals appear when the 
Doppler shift is higher than half of the PRF. Due to aliasing, the wrong colour of fl ow 
direction and incorrect relative velocity of fl ow are reported.
When a vessel appears larger than its actual size. 
The correct focus point positioning is extremely important to improve the amplitude 
of the echoes produced in the focal area. 
In rheumatology, mirror artefact is sometimes generated by the bone surface that cre-
ates mirror images below the bone profi le. 
Any kind of movement (patient, probe, vessels) generates a Doppler shift, thus caus-
ing the appearance of false signal. To avoid them, both patients and operator should be 
comfortably positioned to remain stationary even during a long examination.
The use of abundant amount of acoustic gel is extremely important to give good 
acoustic adherence between the probe and the skin of the patient. This avoids the 
tendency to apply too much pressure thereby creating fl ow blockage and the genera-
tion of false negatives. 
Depends on the noise caused by the electric circuits and appears, when the gain is too 
high, as a random colour signal in the Doppler image.  
The appearance of false colour foci may sometimes occur when a superfi cial vessel is 
imaged lower in the image either as a simple or a complex reverberation. It sometimes 
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obtained using such a method correlate 
with synovial infl ammation (11).
Analysis of Doppler curves and evalu-
ation of resistance index (RI) is another 
quantitative method applicable for syno-
vial fl ow assessment. Low RI correlates 
with hypervascularisation of the tissues 
indicating a low vessel resistance, con-
versely high RI correlates with sparse 
perfusion and high vessel resistance. 
Contrast agents have been used with the 
aim of increasing the sensitivity of Dop-
pler in the detection of tissue hyperemia 
in different rheumatic diseases (8, 11). 
However, they are not used in clinical 
practice because of their invasiveness 
and high cost. Several quantifi cation 
methods have been used including de-
lineation of the area under the curve for 
a specifi c amount of time, computer-
ised quantifi cation of colour pixel at the 
peak of contrast phase and evaluation 
of steepness of the time-intensity curve 
after bolus injection (8, 11). 
Acquisition and misinterpretation 
of Doppler US
A correct acquisition of PD signal needs: 
neutral patient position and minimal 
probe compression to avoid underestima-
tion (29). Both patient and probe should 
maintain a stationary position during the 
acquisition to avoid fl ash artefacts. Mul-
tiplanar scanning technique is required 
to identify maximal expression of PD 
signal. Table I lists a set of parameters 
and corresponding values which allow 
the achievement of the best setting of the 
US equipment. The decision to use PD 
instead of CD depends on the specifi c 
US equipment since some US systems 
are more sensitive to CD than PD, and 
vice versa. The CD and/or PD acquisi-
tion process using a volumetric probe re-
duces acquisition time, requires no par-
ticular skills, is not operator-dependent 
and allows for a comprehensive storage 
of colour signal. The 3D data set differs 
from conventional 2D sonographic im-
ages because it can be interpreted off-
line by a reader who may not be the op-
erator who acquired the images.
For a correct interpretation of Doppler 
images it is mandatory for the opera-
tor to have an extensive knowledge of 
artefacts (Table II).
Doppler US and other imaging 
techniques
The detection of soft tissue infl amma-
tion can be obtained by various imag-
ing techniques including Doppler tech-
niques, magnetic resonance imaging 
(MRI), triphasic scintigraphy and ar-
throscopy (30). The choice of the most 
appropriate imaging technique is never 
absolute and usually depends on several 
factors, including the suspected abnor-
mality, the examiner’s experience, the 
availability of the techniques, and their 
specifi c advantages, limitations and 
contraindications. 
MRI provides an accurate assessment 
of synovitis and its validity has been the 
object of several investigations (31, 32). 
Its main disadvantages include the need 
to use contrast medium to distinguish 
synovial tissue from synovial fl uid, the 
low availability, the high cost, and the 
long waiting list.
CD or PD US allows for a rapid and 
sensitive multi-site examination which 
can be clinically oriented or based on a 
pre-defi ned scanning protocol (i.e., the 
28-joint count for assessing disease ac-
tivity). Its sensitivity relies on the spe-
cifi c US equipment and is very high at 
the level of superfi cial soft tissue and 
small joints (i.e., metacarpophalangeal 
joints), but it is substantially lower in 
the assessment of deep structures (i.e.,
sacroiliac joints).
Scintigraphy is also indicated when 
multifocal processes have to be as-
sessed and when high sensitivity is re-
quired. However, its main disadvantag-
es include radiation hazards, relatively 
higher costs and lower specifi city.
Arthroscopy allows direct visualisation 
of the synovial tissue and it has been 
used as a gold standard in studies com-
paring imaging modalities to assess in-
tra-articular blood perfusion. Its main 
limitation is the extent of invasiveness 
(33-35).
Conclusion
PD US is a sensitive and reliable meth-
od for longitudinal assessment of dis-
ease activity in patients with chronic 
arthritis. Several investigations have 
indicated its role in monitoring therapy 
even after few weeks of baseline ex-
amination. More recently, evidence has 
Fig. 1. Rheumatoid arthritis. Longitudinal dorsal scan of the proximal interphalangeal joint (A), show-
ing the presence of power Doppler signal in the joint.  (B) longitudinal dorsal scan of the IV compart-
ment of the extensor tendons at the wrist. Hyper-perfusion of the synovial tissue is demonstrated. The 
asterisk indicates synovial proliferation. T = extensor tendon; PP = proximal phalanx; MP = middle 
phalanx. Images taken using a Logiq 9 (General Electric Medical Systems, Milwaukee, WI) equipped 
with a 14 MHz linear probe.
For further ultrasound images, go to www.clinexprheumatol.org/ultrasound
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begun to emerge on the positive correla-
tion between PD US fi ndings and radio-
graphic outcome in patients with early 
rheumatoid arthritis. Thus, we believe 
that the “era” of PD US in daily clinical 
practice and multicentric studies is just 
around the corner.
Links
For ultrasound images, go to: www.
clinexprheumatol.org/ultrasound 
References
  1. FILIPPUCCI E, IAGNOCCO A, MEENAGH G et 
al.: Ultrasound imaging for the rheumatolo-
gist. Clin Exp Rheumatol 2006; 24: 1-5. 
  2. FILIPPUCCI E, IAGNOCCO A, MEENAGH G et 
al.: Ultrasound imaging for the rheumatolo-
gist VII. Ultrasound imaging in rheumatoid 
arthritis. Clin Exp Rheumatol 2007; 25: 5-10.
  3. RIENTE L, DELLE SEDIE A, FILIPPUCCI E et 
al.: Ultrasound imaging for the rheumatolo-
gist IX. Ultrasound imaging in spondyloar-
thritis. Clin Exp Rheumatol 2007; 25: 349-
53. 
  4. RIENTE L, DELLE SEDIE A, FILIPPUCCI E et 
al.: Ultrasound imaging for the rheumatolo-
gist XIV. Ultrasound imaging in connective 
tissue diseases. Clin Exp Rheumatol 2008; 
26: 230-3.
  5. IAGNOCCO A, FILIPPUCCI E, MEENAGH G et 
al.: Ultrasound imaging for the rheumatolo-
gist XI. Ultrasound imaging in regional pain 
syndromes. Clin Exp Rheumatol 2007; 25: 
672-5.
  6. DELLE SEDIE A, RIENTE L, IAGNOCCO A et 
al.: Ultrasound imaging for the rheumatolo-
gist X. Ultrasound imaging in crystal-related 
arthropathies. Clin Exp Rheumatol 2007; 25: 
513-7.
  7. MEENAGH G, FILIPPUCCI E, IAGNOCCO A et 
al.: Ultrasound imaging for the rheumatolo-
gist VIII. Ultrasound imaging in osteoarthri-
tis. Clin Exp Rheumatol 2007; 25: 172-5. 
  8. SCHMIDT WA: Tachnology insight: the role 
of colour and power Doppler ultrasonog-
raphy in rheumatology. Nature Clin Pract
2007; 3: 35-42.
  9. DELLE SEDIE A, RIENTE L, FILIPPUCCI E et 
al.: Ultrasound imaging for the rheumatolo-
gist. XV. Ultrasound imaging in vasculitis. 
Clin Exp Rheumatol 2008; 26: 391-4.
10. TORP PEDERSEN ST, TERSLEV L: Setting and 
artefacts relevant in colour/power Doppler 
ultrasound in rheumatology. Ann Rheum Dis
2008; 67: 143-9.
11. ALBRECHT K, MÜLLER-LADNER U, STRUNK 
J: Quantifi cation of the synovial perfusion 
in rheumatoid arthritis using Doppler ultra-
sonography. Clin Exp Rheumatol 2007; 25: 
630-8. 
12. D’AGOSTINO MA, SAID-NAHAL R, HAC-
QUARD-BOUDER C et al.: Assessment of pe-
ripheral enthesitis in the spondylarthropathies 
by ultrasonography combined with power 
Doppler: a cross-sectional study. Arthritis 
Rheum 2003; 48: 523-33.
13. BALINT PV, KANE D, WILSON H et al.:
Ultrasonography of entheseal insertions in 
the lower limb in spondyloarthropathy. Ann 
Rheum Dis 2002; 61: 905-10.
14. DE MIGUEL E, COBO T, MUÑOZ-FERNÁNDEZ 
S et al.: Validity of enthesis ultrasound as-
sessment in spondylarthropathy. Ann Rheum 
Dis 2008 Apr 7 [Epub ahead of print].
15. TAYLOR PC, STEUER A, GRUBER J et al.: 
Comparison of ultrasonographic assessment 
of synovitis and joint vascularity with ra-
diographic evaluation in a randomized, pla-
cebo-controlled study of infl iximab therapy 
in early rheumatoid arthritis. Arthritis Rheum
2004; 50: 1107-16.
16. IAGNOCCO A, FILIPPUCCI E, PERELLA C et 
al.: Clinical and ultrasonographic monitor-
ing of response to adalimumab treatment in 
rheumatoid arthritis. J Rheumatol 2008; 35: 
35-40.
17. IAGNOCCO A, PERELLA C, NAREDO E et al.: 
Etanercept in the treatment of rheumatoid 
arthritis: clinical follow-up over one year by 
ultrasonography. Clin Rheumatol 2008; 27: 
491-6.
18. FILIPPUCCI E, IAGNOCCO A, SALAFFI F et 
al.: Power Doppler sonography monitor-
ing of synovial perfusion at the wrist joints 
in patients with rheumatoid arthritis treated 
with adalimumab. Ann Rheum Dis 2006; 65: 
1433-7.
19. FILIPPUCCI E, FARINA A, CAROTTI M, 
SALAFFI F, GRASSI W: Grey scale and power 
Doppler sonographic changes induced by in-
tra-articular steroid injection treatment. Ann 
Rheum Dis 2004; 63: 740-3.
20. HAU M, KNEITZ C, TONY HP et al.: High res-
olution ultrasound detects a decrease in pan-
nus vascularisation of small fi nger joints in 
patients with rheumatoid arthritis receiving 
treatment with soluble tumour necrosis fac-
tor alpha receptor (etanercept). Ann Rheum 
Dis 2002; 61: 55-8.
21. NAREDO E, COLLADO P, CRUZ A et al.: 
Longitudinal power Doppler ultrasonograph-
ic assessment of joint infl ammatory activity 
in early rheumatoid arthritis: predictive value 
in disease activity and radiologic progres-
sion. Arthritis Rheum 2007; 57: 116-24
22. BROWN AK, QUINN MA, KARIM Z et al.: 
Presence of signifi cant synovitis in rheu-
matoid arthritis patients with disease-modi-
fying antirheumatic drug-induced clinical 
remission: evidence from an imaging study 
may explain structural progression. Arthritis 
Rheum 2006; 54: 3761-73.
23. KOSKI JM, SAARAKKALA S, HELLE M et al.: 
Assessing the intra- and inter-reader reliabil-
ity of dynamic ultrasound images in power 
Doppler ultrasonography. Ann Rheum Dis
2006; 65: 1658-60.
24. ALBRECHT K, GROB K, LANGE U, MÜLLER-
LADNER U, STRUNK J: Reliability of different 
Doppler ultrasound quantifi cation methods 
and devices in the assessment of therapeutic 
response in arthritis. Rheumatology (Oxford) 
2008; 47: 1521-6. 
25. TERSLEV L, TORP-PEDERSEN S, BANG N, 
KOENIG MJ, NIELSEN MB, BLIDDAL H: Dop-
pler ultrasound fi ndings in healthy wrists and 
fi nger joints before and after use of two dif-
ferent contrast agents. Ann Rheum Dis 2005; 
64: 824-7.
26. NAREDO E, MÖLLER I, CRUZ A, CARMONA 
L, GARRIDO J: Power Doppler ultrasono-
graphic monitoring of response to anti-tumor 
necrosis factor therapy in patients with rheu-
matoid arthritis. Arthritis Rheum 2008; 58: 
2248-56.
27. NAREDO E, RODRIGUEZ M, CAMPOS C et al.: 
Validity, reproducibility and responsiveness 
of a twelve-joint simplifi ed power Doppler 
ultrasonographic assessment of joint infl am-
mation in rheumatoid arthritis. Arthritis 
Rheum 2008; 59: 515-22.
28. D’AGOSTINO MA, SAID-NAHAL R, HAC-
QUARD-BOUDER C, BRASSEUR JL, DOUGA-
DOS M, BREBAN M: Assessment of periph-
eral enthesitis in the spondylarthropathies by 
ultrasonography combined with power Dop-
pler: a cross-sectional study. Arthritis Rheum
2003; 48: 523-33.
29. JOSHUA F, DE CARLE R, RAYMENT M et al.: 
Power Doppler ‘blanching’ after the applica-
tion of transducer pressure. Australas Radiol
2005; 49: 218-21.
30. GRASSI W, FILIPPUCCI E, CAROTTI M, 
SALAFFI F: Imaging modalities for identify-
ing the origin of regional musculoskeletal 
pain. Best Pract Res Clin Rheumatol 2003; 
17: 17-32.
31. ØSTERGAARD M, STOLTENBERG M, LØV-
GREEN-NIELSEN P, VOLCK B, JENSEN CH, 
LORENZEN I: Magnetic resonance imaging-
determined synovial membrane and joint ef-
fusion volumes in rheumatoid arthritis and 
osteoarthritis. Comparison with the macro-
scopic and microscopic appearance of the 
synovium. Arthritis Rheum 1997; 40: 1856-
67. 
32. ØSTERGAARD M, SZKUDLAREK M: Imaging 
in rheumatoid arthritis – why MRI and ultra-
sonography can no longer be ignored. Scand 
J Rheumatol 2003; 32: 63-73.
33. KARIM Z, RJ WAKEFIELD, M QUINN et al.: 
Validation and reproducibility of ultrasonog-
raphy in the detection of synovitis in the 
knee: A comparison with arthroscopy and 
clinical examination. Arthritis Rheum 2004; 
50: 387-94.
34. FIOCCO U, FERRO F, COZZI L et al.: Contrast 
medium in power Doppler ultrasound for as-
sessment of synovial vascularity: compari-
son with arthroscopy. J Rheumatol 2003; 30: 
2170-6.
35. ØSTERGAARD M: Quantitative magnetic 
resonance imaging as marker of synovial 
membrane regeneration and recurrence of 
synovitis after arthroscopic knee joint syn-
ovectomy: a one year follow up study. Ann 
Rheum Dis 2001; 60: 233-6.
